Skip to content

Opening book details…

About this Medicine article

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data by J.-L. Chiasson; R. G. Josse; R. Gomis; M. Hanefeld; A. Karasik; M. Laakso; the STOP-NIDDM Trial Research Group is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
J.-L. Chiasson; R. G. Josse; R. Gomis; M. Hanefeld; A. Karasik; M. Laakso; the STOP-NIDDM Trial Research Group
Publisher
Springer; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0012-186X)
Published
2004
Language
EN
Field
Medicine (Health Sciences)

More by J.-L. Chiasson; R. G. Josse; R. Gomis; M. Hanefeld; A. Karasik; M. Laakso; the STOP-NIDDM Trial Research Group

Browse all works by J.-L. Chiasson; R. G. Josse; R. Gomis; M. Hanefeld; A. Karasik; M. Laakso; the STOP-NIDDM Trial Research Group